"No-Observed-Adverse-Effect Level"[MAJR] - Search Results

Year	Number of Results
1964	1
1995	1
1996	2
1997	1
1998	3
1999	1
2000	1
2002	2
2003	2
2004	3
2005	3
2006	1
2008	1
2009	3
2010	1
2011	2
2012	1
2013	3
2014	2
2015	6
2016	17
2017	12
2018	10
2019	6
2020	8
2021	3
2023	1
2024	1

1

Preexisting diabetes mellitus had no effect on the no-observed-adverse-effect-level of acetaminophen in rats.

Kishi S, Yamakawa K, Nakano-Narusawa Y, Kanie S, Hashimoto N, Saoo K, Yokohira M, Imaida K, Matsuda Y. Kishi S, et al. J Toxicol Sci. 2020;45(3):151-162. doi: 10.2131/jts.45.151. J Toxicol Sci. 2020. PMID: 32147638 Free article.

2

An FDA oncology analysis of CD3 bispecific constructs and first-in-human dose selection.

Saber H, Del Valle P, Ricks TK, Leighton JK. Saber H, et al. Regul Toxicol Pharmacol. 2017 Nov;90:144-152. doi: 10.1016/j.yrtph.2017.09.001. Epub 2017 Sep 5. Regul Toxicol Pharmacol. 2017. PMID: 28887049 Review.

3

Astaxanthin: How much is too much? A safety review.

Brendler T, Williamson EM. Brendler T, et al. Phytother Res. 2019 Dec;33(12):3090-3111. doi: 10.1002/ptr.6514. Epub 2019 Dec 1. Phytother Res. 2019. PMID: 31788888 Review.

4

[Study of No Observed Adverse Effect Level of Nickel and Its Preliminary Evaluation Biocompatibility].

He X, Tang J, Wen X, Guan B, Wang R, Wang H, Li H, Shi J, Zeng Y, Mao Y. He X, et al. Zhongguo Yi Liao Qi Xie Za Zhi. 2020 Oct 8;44(5):448-452. doi: 10.3969/j.issn.1671-7104.2020.05.016. Zhongguo Yi Liao Qi Xie Za Zhi. 2020. PMID: 33047572 Chinese.

5

Don't be fooled-A no-observed-effect concentration is no substitute for a poor concentration-response experiment.

Fox DR, Landis WG. Fox DR, et al. Environ Toxicol Chem. 2016 Sep;35(9):2141-8. doi: 10.1002/etc.3459. Epub 2016 Jun 28. Environ Toxicol Chem. 2016. PMID: 27089534 Review.

6

In Silico Models for Repeated-Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs.

Pizzo F, Benfenati E. Pizzo F, et al. Methods Mol Biol. 2016;1425:163-76. doi: 10.1007/978-1-4939-3609-0_9. Methods Mol Biol. 2016. PMID: 27311467

7

D-10-camphorsulfonic acid: Safety evaluation.

Fehr M, Appl Á, Esdaile DJ, Naumann S, Schulz M, Dahms I. Fehr M, et al. Mutat Res Genet Toxicol Environ Mutagen. 2020 Oct-Dec;858-860:503257. doi: 10.1016/j.mrgentox.2020.503257. Epub 2020 Sep 22. Mutat Res Genet Toxicol Environ Mutagen. 2020. PMID: 33198938 Free article.

8

Admissible daily intake for glutamate.

Tomé D. Tomé D. Curr Opin Clin Nutr Metab Care. 2020 Mar;23(2):133-137. doi: 10.1097/MCO.0000000000000624. Curr Opin Clin Nutr Metab Care. 2020. PMID: 31815766 Review.

9

An updated evaluation of reported no-observed adverse effect levels for chrysotile asbestos for lung cancer and mesothelioma.

Pierce JS, Ruestow PS, Finley BL. Pierce JS, et al. Crit Rev Toxicol. 2016 Aug;46(7):561-86. doi: 10.3109/10408444.2016.1150960. Epub 2016 Mar 31. Crit Rev Toxicol. 2016. PMID: 27031024

10

Point of departure (PoD) selection for the derivation of acceptable daily exposures (ADEs) for active pharmaceutical ingredients (APIs).

Bercu JP, Morinello EJ, Sehner C, Shipp BK, Weideman PA. Bercu JP, et al. Regul Toxicol Pharmacol. 2016 Aug;79 Suppl 1:S48-56. doi: 10.1016/j.yrtph.2016.05.028. Epub 2016 May 24. Regul Toxicol Pharmacol. 2016. PMID: 27233925 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year